Illumina Appoints Mike Sullivan as CCO July 20 and Julie Coletti as CLO August 3
ILMN•Illumina named Mike Sullivan as Chief Commercial Officer effective July 20, 2026, and Julie Coletti as Chief Legal Officer effective August 3, 2026. Sullivan brings over 30 years’ diagnostics and precision medicine commercial leadership, while Coletti offers regulatory and governance expertise from roles at Align Technology, Danaher and Bayer HealthCare.
1. New Executive Appointments
Illumina announced the hiring of Mike Sullivan as Chief Commercial Officer starting July 20, 2026, and Julie Coletti as Chief Legal Officer effective August 3, 2026, adding two senior executives to its leadership team.
2. Chief Commercial Officer Profile
Mike Sullivan joins with more than 30 years of commercial leadership experience in diagnostics, precision medicine and healthcare, having led global teams at Caris Life Sciences, Roche Diagnostics, Ortho Clinical Diagnostics, IDEXX Laboratories and Abbott Diagnostics.
3. Chief Legal Officer Profile
Julie Coletti brings extensive legal, regulatory and governance expertise from her tenure as Chief Legal and Regulatory Officer at Align Technology and senior legal roles at Danaher and Bayer HealthCare, and serves as board director at Fortis Life Sciences.
4. Strategic Outlook
These appointments reinforce Illumina’s focus on scaling its commercial operations and strengthening legal and regulatory oversight as the company advances its genomics and multiomics growth strategy.
